BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22983148)

  • 1. Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA.
    Kubo T; Yanagihara K; Sato Y; Morita Y; Seyama T
    Molecules; 2012 Sep; 17(9):11089-102. PubMed ID: 22983148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
    Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
    Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified 27-nt dsRNAs with dramatically enhanced stability in serum and long-term RNAi activity.
    Kubo T; Zhelev Z; Ohba H; Bakalova R
    Oligonucleotides; 2007; 17(4):445-64. PubMed ID: 17894530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent RNAi by short RNA triggers.
    Chu CY; Rana TM
    RNA; 2008 Sep; 14(9):1714-9. PubMed ID: 18658119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nanoparticle conjugation on gene silencing by RNA interference.
    Singh N; Agrawal A; Leung AK; Sharp PA; Bhatia SN
    J Am Chem Soc; 2010 Jun; 132(24):8241-3. PubMed ID: 20518524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational study of off-target effects of RNA interference.
    Qiu S; Adema CM; Lane T
    Nucleic Acids Res; 2005; 33(6):1834-47. PubMed ID: 15800213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.
    Chiu YL; Ali A; Chu CY; Cao H; Rana TM
    Chem Biol; 2004 Aug; 11(8):1165-75. PubMed ID: 15324818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.
    Vengut-Climent E; Terrazas M; Lucas R; Arévalo-Ruiz M; Eritja R; Morales JC
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4048-51. PubMed ID: 23764303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate-binding pocket in Dicer-2 PAZ domain for high-fidelity siRNA production.
    Kandasamy SK; Fukunaga R
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):14031-14036. PubMed ID: 27872309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
    Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
    Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
    Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
    Kubo T; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.